[1]
“Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital”, Acta Biomed, vol. 92, no. S6, p. e2021450, Oct. 2021, doi: 10.23750/abm.v92iS6.12217.